MHRA Drug Safety Update October 2021

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 15 Issue 3 October 2021) has been published and includes articles on:

  • Tofacitinib (Xeljanz▼): new measures to minimise risk of major adverse cardiovascular events and malignancies
  • Chloral hydrate, cloral betaine (Welldorm): restriction of paediatric indication
  • MedSafetyWeek November 2021: support the safety of vaccines
  • COVID-19 vaccines: updates for October 2021
  • Letters and medicine recalls sent to healthcare professionals in September 2021

To see the latest MHRA Drug Safety Updates in full, visit the website